Capreomycin ib
- Level
- Commodity
- Parent
- 51281600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281640This classification denotes an antitubercular agent and aminoglycoside antibiotic with the molecular formula C25H44N14O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2YP3RYC823, chemically known as cyclo((2s)-2-amino-.beta.-alanyl-l-alanyl-3-(((3s)-3,6-diamino-1-oxohexyl)amino)-l-alanyl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-(2s)-2-((4r)-2-amino-3,4,5,6-tetrahydro-4-pyrimidinyl)glycyl), but more generally known as capreomycin ib, which bears US NIH Compound Identifier 3034057. European Medicines Agency schedules capreomycin ib or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01028MIG. Most nations, for tariff purposes, schedule capreomycin ib under HS 29419000. SMILES: C[C@H]1C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N[C@H](C(=O)NC[C@@H](C(=O)N1)N)[C@H]2CCN=C(N2)N)CNC(=O)C[C@H](CCCN)N.
Same parent
Under 51281600 · 75Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.